GlassScriptPhysician profile
Geoffrey C Cly
NPI 1407855802
$1,640.65
in general payments reported to CMS, 2019-2025
15 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $27.58 · 2021: $568 · 2023: $34.17 · 2024: $592 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $765.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $617.51 | 2019-2023 | |
| Caldera Medical, INC | $256.14 | 2024 | Desara |
| Biogen, INC. | $222.23 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $185.52 | 2021-2024 | Acessa Provu System, Myosure Tissue Removal Device |
| Abbvie INC. | $121.86 | 2019 | |
| Pfizer INC. | $53.54 | 2019-2023 | |
| Dexcom, INC. | $47.86 | 2025 | Dexcom G6 Transmitter |
| Amag Pharmaceuticals, INC. | $29.00 | 2019 | |
| Sumitomo Pharma America, INC. | $19.14 | 2025 | Myfembree |
| Myovant Sciences INC. | $16.35 | 2021 | |
| Coopersurgical, INC. | $16.24 | 2021 | |
| Acella Pharmaceuticals, LLC | $15.05 | 2025 | NP Thyroid 60 |
| Boston Scientific Corporation | $14.61 | 2019 | |
| Minerva Surgical, INC | $12.94 | 2019 | |
| Ethicon US, LLC | $12.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geoffrey Cly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.